| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.572 | 0.004 | 0.572 | Interleukin 6 antagonist | 0.141 0.104 CID_22618433 | ||
| 0.465 | 0.005 | 0.465 | Interleukin 1 antagonist | |||
| 0.393 | 0.032 | 0.393 | Interleukin antagonist | |||
| 0.292 | 0.007 | 0.292 | MAP kinase 12 inhibitor | 0.181 0.029 CID_22618433 | ||
| 0.282 | 0.003 | 0.282 | GABA B receptor antagonist | 0.086 0.005 CID_22618433 | ||
| 0.233 | 0.003 | 0.238 | CXC chemokine 1 receptor antagonist | 0.238 0.003 CID_22618433 | CID_22618433 | |
| 0.254 | 0.048 | 0.254 | Peptidyltransferase inhibitor | |||
| 0.202 | 0.02 | 0.202 | MAP kinase 13 inhibitor | |||
| 0.18 | 0.012 | 0.18 | MAP kinase 11 inhibitor | 0.082 0.047 CID_22618433 | ||
| 0.164 | 0.011 | 0.176 | Cyclin B3 inhibitor | 0.176 0.009 CID_22618433 | CID_22618433 | |
| 0.261 | 0.135 | 0.261 | Calcium channel activator | |||
| 0.129 | 0.014 | 0.151 | CXC chemokine receptor antagonist | 0.151 0.01 CID_22618433 | CID_22618433 | |
| 0.108 | 0.014 | 0.298 | GABA receptor antagonist | 0.298 0.004 CID_22618433 | CID_22618433 | |
| 0.132 | 0.041 | 0.161 | Chemokine receptor antagonist | 0.161 0.028 CID_22618433 | CID_22618433 | |
| 0.095 | 0.017 | 0.155 | GABA A receptor antagonist | 0.155 0.008 CID_22618433 | CID_22618433 | |
| 0.102 | 0.027 | 0.102 | Thioredoxin reductase inhibitor | |||
| 0.235 | 0.161 | 0.458 | Toll-Like receptor 7 agonist | 0.458 0.041 CID_22618433 | CID_22618433 | |
| 0.128 | 0.056 | 0.128 | Interleukin 1b antagonist | |||
| 0.104 | 0.033 | 0.104 | MAP kinase 14 inhibitor | 0.064 0.061 CID_22618433 | ||
| 0.08 | 0.013 | 0.08 | H+/K+-transporting ATPase inhibitor | |||
| 0.232 | 0.166 | 0.455 | Toll-Like receptor agonist | 0.455 0.042 CID_22618433 | CID_22618433 | |
| 0.185 | 0.122 | 0.185 | Tumour necrosis factor alpha release inhibitor | |||
| 0.081 | 0.021 | 0.081 | Cyclin B1 inhibitor | 0.071 0.031 CID_22618433 | ||
| 0.081 | 0.024 | 0.081 | Exportin-1 inhibitor | |||
| 0.073 | 0.019 | 0.073 | Cyclin B2 inhibitor | 0.062 0.03 CID_22618433 | ||
| 0.114 | 0.063 | 0.114 | CDK3/cyclin E inhibitor | |||
| 0.163 | 0.117 | 0.163 | EphB2 antagonist | |||
| 0.129 | 0.089 | 0.182 | Cyclooxygenase inhibitor | 0.182 0.049 CID_22618433 | CID_22618433 | |
| 0.064 | 0.027 | 0.064 | Cyclin B inhibitor | 0.055 0.039 CID_22618433 | ||
| 0.092 | 0.062 | 0.092 | Uric acid excretion stimulant | |||
| 0.112 | 0.089 | 0.174 | Cyclooxygenase 2 inhibitor | 0.174 0.04 CID_22618433 | CID_22618433 | |
| 0.124 | 0.105 | 0.124 | Insulin secretagoues | |||
| 0.039 | 0.038 | 0.039 | Neurokinin 3 antagonist | |||
| 0.068 | 0.073 | 0.092 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.092 0.041 CID_22618433 | CID_22618433 | |
| 0.089 | 0.112 | 0.295 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.295 0.018 CID_22618433 | CID_22618433 | |
| 0.014 | 0.05 | 0.034 | CXC chemokine 2 receptor antagonist | 0.034 0.011 CID_22618433 | CID_22618433 | |
| 0.041 | 0.086 | 0.06 | Cannabinoid CB1 receptor antagonist | 0.06 0.045 CID_22618433 | CID_22618433 | |
| 0.064 | 0.111 | 0.108 | Potassium channel activator | 0.108 0.041 CID_22618433 | CID_22618433 | |
| 0.157 | 0.212 | 0.197 | Neuropeptide Y2 antagonist | 0.197 0.124 CID_22618433 | CID_22618433 | |
| 0.057 | 0.153 | 0.112 | c-Src kinase inhibitor | 0.112 0.081 CID_22618433 | CID_22618433 | |
| 0.09 | 0.194 | 0.117 | Sphingosine 1-phosphate receptor 2 antagonist | 0.117 0.104 CID_22618433 | CID_22618433 | |
| 0.03 | 0.144 | 0.11 | Cannabinoid receptor antagonist | 0.11 0.025 CID_22618433 | CID_22618433 | |
| 0.01 | 0.144 | 0.036 | Liver X receptor antagonist | 0.036 0.017 CID_22618433 | CID_22618433 | |
| 0.055 | 0.19 | 0.094 | ABCA1 expression enhancer | 0.094 0.059 CID_22618433 | CID_22618433 | |
| 0.056 | 0.193 | 0.131 | Cyclooxygenase 1 inhibitor | 0.131 0.07 CID_22618433 | CID_22618433 | |
| 0.01 | 0.156 | 0.031 | Liver X receptor alpha antagonist | 0.031 0.017 CID_22618433 | CID_22618433 | |
| 0.021 | 0.187 | 0.052 | Neuropeptide Y5 antagonist | 0.052 0.035 CID_22618433 | CID_22618433 | |
| 0.009 | 0.24 | 0.05 | Cannabinoid CB2 receptor antagonist | 0.05 0.037 CID_22618433 | CID_22618433 | |
| 0.011 | 0.246 | 0.058 | Liver X receptor agonist | 0.058 0.018 CID_22618433 | CID_22618433 | |
| 0.054 | 0.293 | 0.132 | LIM domain kinase 1 inhibitor | 0.132 0.118 CID_22618433 | CID_22618433 | |
| 0.025 | 0.347 | 0.092 | DNA helicase inhibitor | 0.092 0.007 CID_22618433 | CID_22618433 | |
| 0.063 | 0.47 | 0.148 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.148 0.136 CID_22618433 | CID_22618433 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |